@ivivek87 Been there done that @MayoClinic_KLab almost a decade ago. https://t.co/Nvf2oLrx3p 95%of GWAS is leading to non-coding/regulatory biology. 9p21 is a classic example. It's high time we explore the druggable targets in the space.
Very happy to be the lead author of one the first #PheWAS papers - no doubt it’s a unique way to delineate pleitropy-driven regulatory effects. https://t.co/pNCkc5RVF1 Glad to see it’s impact in #drugdiscovery and watch this space for our collaborative
RT @kshameer: @rplenge @bloodgenes @manuelrivascruz Very exciting! Lead one of the first GWAS-PheWAS (platelets) study as a post-doc @May…
@rplenge @bloodgenes @manuelrivascruz Very exciting! Lead one of the first GWAS-PheWAS (platelets) study as a post-doc @MayoClinic_KLab. https://t.co/pNCkc5RVF1
@bloodgenes @skathire We should write a response to Nature highlighting all that + insights from PheWAS. E.g. https://t.co/pNCkc5RVF1 https://t.co/brf7HeKvdX
RT @kshameer: Proud and happy. Worked on the data during my Post doc. Lead the first genomics-phenomics study using the data. https://t.co…
RT @kshameer: Proud and happy. Worked on the data during my Post doc. Lead the first genomics-phenomics study using the data. https://t.co…
Proud and happy. Worked on the data during my Post doc. Lead the first genomics-phenomics study using the data. https://t.co/jQ3TtbnDQk https://t.co/PUvwp9AN48